GLP-3 R 30mg
$349.99
GLP-3 R 30mg
Retatrutide
CAS: 2381609-35-2
Retatrutide (GLP-3 R) 30mg — extended supply at the best value per mg. Full escalation cycle in one vial.
For research purposes only. Not intended for human use.
Triple-Agonist: GLP-1R + GIPR + GcgR
Same Retatrutide compound as all GLP-3 R vials. Triple receptor agonism — GLP-1, GIP, and Glucagon. Phase 2 data: −28.7% at 8mg/week, 48 weeks. The 30mg vial provides double the supply of the standard 15mg at $11.67/mg vs $12.67/mg.
Best Value Per mg
30mg at $349.99 = $11.67/mg. 15mg at $189.99 = $12.67/mg. The 30mg saves approximately $1/mg over the standard vial — significant for extended protocols.
Full Escalation Cycle
A complete Phase 2 escalation (2mg × 4 weeks + 4mg × 4 weeks + 8mg × remaining) consumes approximately 25-30mg for a 12-week cycle. The 30mg vial covers a full cycle.
Extended Protocol Supply
For protocols extending beyond 12 weeks, the 30mg provides continuity without needing to reorder. Reconstituted at 3mg/mL from 10mL BAC water.
Specifications
Research FAQ
Is the 30mg vial better value than two 15mg vials?
Yes — 30mg at $349.99 ($11.67/mg) vs two 15mg at $379.98 ($12.67/mg). The 30mg saves approximately $30 for the same total supply.
Related Products
GLP-3 R 10mg
Retatrutide (GLP-3 R) 10mg — starter supply for triple GLP-1/GIP/Glucagon receptor agonist research. The entry-level Clav stack compound. Phase 2: −28.7% body weight at 48 weeks. >98% purity, HPLC tested, lyophilized.
CAS: 2381609-35-2
